Agency issues precautionary recall due to manufacturing fault.
The Medicines and Healthcare products Regulatory Agency (MHRA) has recalled drugs made by Boots UK due to a possible fault in the manufacturing process of the tamper seal that might result in small pieces of plastic being found in the liquid medicines. This follows a precautionary recall by the pharmacy-led retailer in November 2013 asking patients to return specific cough and cold medicines purchased since September 2013.
“This is a precautionary recall by Boots and there is a low risk of plastic being found in bottles. There is currently no evidence that people have had any problems with these medicines.People should check their medicine cupboards at home and return these products to Boots. If people have any questions, they should contact Boots Customer Care Team or they can speak to their GP,” says Adam Burgess, the MHRA’s Head of Defective Medicines Reporting Centre (DMRC) in a press release.
Boots has extended the scope of the original recall to include further batches and medicines, and is asking patients to return all batches of specific paracetamol, gripe mixture, and cough and cold medicines. While there is currently no evidence of problems resulting from this manufacturing fault, customers are being asked to return the following medicines to Boots as a precautionary measure:
Source: MHRA
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
AES Clean Technology Launches Next-Generation OSM Utility Solution for Cleanrooms at INTERPHEX 2025
April 2nd 2025Officially launched at INTERPHEX 2025, the Omni ASCENT is a next-generation off-site manufactured vertical utility solution that offers optimized cleanroom flexibility and efficiency.